SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950133-01-001009
Filing Date
2001-03-22
Accepted
2001-03-22 00:00:00
Documents
1
Group Members
BB BIOTECH AGBIOTECH TARGET S.A.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G w46896asc13g.txt SC 13G 18346
  Complete submission text file 0000950133-01-001009.txt   20431
Mailing Address 10555 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address 10555 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 8586587600
NEUROCRINE BIOSCIENCES INC (Subject) CIK: 0000914475 (see all company filings)

IRS No.: 330525145 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-46089 | Film No.: 1576449
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BAKER & MCKENZIE 815 CONNECTICUT AVENUE NW WASHINGTON DC 20006
Business Address C/O BAKER & MCKENZIE 815 CONNECTICUT AVENUE NW WASHINGTON DC 20006 2028351882
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

State of Incorp.: DC | Fiscal Year End: 1231
SIC: 0000